TLR4 and gastric cancer: DO can also alleviate lipopolysaccharides (LPS)-induced gastric cancer cell injury by inhibiting TLR4 signaling and can reverse intestinal epithelial cell damage by regulating TLR4 (Zhang et al., 2019; Yang K, et al., 2020).